Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

Article Details

Citation

King BP, Khan TI, Aithal GP, Kamali F, Daly AK

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

Pharmacogenetics. 2004 Dec;14(12):813-22.

PubMed ID
15608560 [ View in PubMed
]
Abstract

OBJECTIVES: To assess whether CYP2C9 alleles other than CYP2C9*2 and *3 are associated with a low-warfarin dose requirement and the relevance of upstream CYP2C9 polymorphisms to dose requirement and metabolism. METHODS: CYP2C9 exons, intron-exon boundaries and 3 kb of upstream sequence in 20 patients requiring or= 0.01, was obtained. In individuals negative for coding region polymorphisms, neither individual genotypes for T-1188C or DeltaG-2664DeltaT-2665 or particular combinations of haplotype pairs were predictive of dose requirement or S-warfarin total clearance, suggesting neither upstream polymorphism was functionally significant. Dose requirements in CYP2C9*11 heterozygotes were not statistically significantly different from homozygous wild-type individuals. CONCLUSIONS: The coding region non-synonymous polymorphisms associated with the CYP2C9*2 and CYP2C9*3 alleles are the major CYP2C9-related factor affecting warfarin dose in UK Caucasians. Upstream CYP2C9 polymorphisms do not appear to be important independent determinants of dose requirement.

DrugBank Data that Cites this Article

Pharmaco-genomics
DrugInteracting Gene/EnzymeAllele nameGenotypesDefining change(s)Type(s)DescriptionDetails
WarfarinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2(T;T) / (C;T)Effect Directly StudiedPatients with this genotype have reduced metabolism of warfarin.Details
PhenytoinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
PhenytoinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
CelecoxibCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
CelecoxibCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
WarfarinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*3Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
WarfarinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
ClopidogrelCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirements, higher risk for drug-drug interactionsDetails
ClopidogrelCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirements, higher risk for drug-drug interactionsDetails
Acetylsalicylic acidCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
Acetylsalicylic acidCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
GlipizideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
GlipizideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
TolbutamideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
TolbutamideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
AcenocoumarolCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableEffect InferredPoor drug metabolizer, associated with lower dose requirement.Details
PhenprocoumonCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*3Not AvailableADR InferredAssociated with delayed stabilization. If carrier of rs9934438 as well, increased risk of severe overanticoagulation.Details
PhenprocoumonCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*11Not AvailableADR InferredAssociated with delayed stabilization. If carrier of rs9934438 as well, increased risk of severe overanticoagulation.Details